LeMaitre Vascular Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
Medical Device Stocks To Beat Estimates This Earnings Season
Article By: Zacks Investment Research
Wednesday, April 19, 2017 4:16 AM EDT
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease. The past six months were very favorable for the stock rising almost 29%.
In this article: LMAT, CMRX, HRC
Read
E Small Cap Best And Worst - September 15, 2016
Article By: E.B. Capital Markets
Thursday, September 15, 2016 9:56 AM EDT
The average small cap score this week is 51.79. For perspective, the average small cap score over the past four weeks is 54.14.
In this article: BGC, CRY, OXM, SRI, XOXO, BABY, BEAT, LMAT, NTCT, SIGM, TSYS, CFNL, DAKT, GIFI, IART, BCOR, PROV, TASR, WRLD, NWBI
Read
4 Growth Stocks That Continue To Crush Earnings Estimates
Article By: Zacks Investment Research
Friday, September 11, 2015 5:41 PM EDT
Corporate earnings are probably the most keenly watched events by investors. Earnings theoretically determine the growth or contraction of companies as well as their stocks.
In this article: DY, ELLI, LMAT, TREE
Read
LeMaitre Vascular - All Time High
Article By: Jim Van Meerten
Sunday, May 10, 2015 9:24 AM EDT
Lemaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons.
In this article: LMAT
Read
CVS Health Q1 Earnings Beat, Grow Y/Y; EPS View Raised
Article By: Zacks Investment Research
Friday, May 1, 2015 12:05 PM EDT
CVS Health posted yet another solid quarter with both earnings and revenues exceeding the respective Consensus Estimate by decent margins.
In this article: CVS, HSP, SRDX, LMAT
Read

PARTNER HEADLINES

Latest Tweets for $LMAT

No tweets yet!